|
HIMSS Board Chair Willa Fields, DNSc, RN, FHIMSS, professor, School of Nursing, San Diego State University, will act as a witness to the Subcommittee on Technology and Innovation, providing testimony stating that Meaningful Use is delivering meaningful results during a hearing that will take place this morning at 10 a.m. EST.
Fields will act as witness to the success of Meaningful Use, along with Frazad Mostashari, MD, National Coordinator for Health Information Technology, Office of the National Coordinator for Health Information Technology; Charles Romine, PhD, director, Information Technology Laboratory, National Institute of Standards and Technology; Marc Probst, chief information officer and vice president, Information Systems, Intermountain Healthcare; and Rebecca Little, senior vice president, Medicity.
In her testimony, Fields will present the HIMSS perspective that Meaningful Use and the Stage 2 regulations allow the healthcare community to continue the necessary steps to ensure health information technology will support the transformation of healthcare delivery in the U.S.
The testimony will be webcast live, and Fields' comments will be posted after her testimony on the HIMSS Public Policy and Advocacy page under Testimony.
|